- Home
- CLDI vs IHT Comparison
CLDI vs IHT Comparison
Compare CLDI & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- IHT
- Stock Information
- Founded
- CLDI 2014
- IHT 1971
- Country
- CLDI United States
- IHT United States
- Employees
- CLDI N/A
- IHT N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- IHT Investment Bankers/Brokers/Service
- Sector
- CLDI Health Care
- IHT Finance
- Exchange
- CLDI Nasdaq
- IHT Nasdaq
- Market Cap
- CLDI 14.0M
- IHT 21.2M
- IPO Year
- CLDI N/A
- IHT N/A
- Fundamental
- Price
- CLDI $0.48
- IHT $2.44
- Analyst Decision
- CLDI Strong Buy
- IHT
- Analyst Count
- CLDI 2
- IHT 0
- Target Price
- CLDI $15.00
- IHT N/A
- AVG Volume (30 Days)
- CLDI 387.2K
- IHT 3.5K
- Earning Date
- CLDI 05-13-2025
- IHT 06-17-2025
- Dividend Yield
- CLDI N/A
- IHT 0.82%
- EPS Growth
- CLDI N/A
- IHT N/A
- EPS
- CLDI N/A
- IHT N/A
- Revenue
- CLDI N/A
- IHT $7,692,305.00
- Revenue This Year
- CLDI N/A
- IHT N/A
- Revenue Next Year
- CLDI N/A
- IHT N/A
- P/E Ratio
- CLDI N/A
- IHT N/A
- Revenue Growth
- CLDI N/A
- IHT 4.55
- 52 Week Low
- CLDI $0.35
- IHT $1.25
- 52 Week High
- CLDI $4.90
- IHT $2.70
- Technical
- Relative Strength Index (RSI)
- CLDI 38.20
- IHT 51.07
- Support Level
- CLDI $0.45
- IHT $2.36
- Resistance Level
- CLDI $0.52
- IHT $2.45
- Average True Range (ATR)
- CLDI 0.07
- IHT 0.05
- MACD
- CLDI 0.02
- IHT 0.01
- Stochastic Oscillator
- CLDI 60.10
- IHT 68.42
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.